Skip to main content

AI Model IDs Women With Subjective Cognitive Decline During Menopause

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 22, 2025.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 22, 2025 -- Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) during the menopause transition, according to a study published online Jan. 14 in Menopause.

Xiangyu Zhao, from Shandong University in Jinan, China, and colleagues developed and validated a machine learning model for identifying individuals experiencing severe SCD during the menopause transition. The analysis included data from 1,264 nurses.

The researchers found that the Bortua algorithm (a feature-selection algorithm) identified 13 significant associated factors. The support vector machine exhibited the best overall performance out of the seven models, achieving an area under the receiver operating characteristic curve of 0.846, accuracy of 0.789, sensitivity of 0.753, specificity of 0.802, and an F1 score of 0.658. Menopausal symptoms and the stage of menopause were the two variables most strongly associated with SCD.

"This study highlights how the use of machine learning can be employed to identify women experiencing severe SCD during the menopause transition and potential associated factors," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "Early identification of high-risk persons may allow for targeted interventions to protect cognitive health. Future studies involving objective measures of cognition and longitudinal follow-up are crucial to better understanding these associations."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...

Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease

TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...

Overwork Tied to Structural Changes in Brains of Health Care Workers

MONDAY, May 19, 2025 -- Overwork in health care workers is associated with structural brain changes, particularly in regions linked to cognition and emotion, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.